Study the effectiveness of Hydroxyzine hydrochloride in Patients with Persistent Itching

Real world Non-interventional Observational Study of Hydroxyzine hydrochloride in Chronic Pruritus

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/06/008847

Enrollment

400

Registered

2017-06-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Pruritus

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients clinically diagnosed with chronic pruritus due to dermatological conditions where physician has taken decision to prescribe hydroxyzine hydrochloride. 2. Patients aged 18 years to 50 years who provide informed consent for data collection. 3. Patients of both sexes.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic pruritus due to systemic causes. 2. Patients with known hypersensitivity to hydroxyzine hydrochloride or any component of this medication. 3. Females who are pregnant or are lactating. 4. Patients on other CNS medications, or known neurological conditions.

Design outcomes

Primary

Measure	Time frame
Effectiveness of hydroxyzine hydrochloride in improving Quality of Life will be recorded using the DLQI questionnaire at the end of 12 weeks compared to baselineTimepoint: 12 weeks	—

Secondary

Measure	Time frame
Effectiveness of hydroxyzine hydrochloride in improvement of pruritus, will be recorded using the 5D Itch Scale at the end of 12 weeks compared to baselineTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr DG Saple

La Mer Clinic

clinic@drsaple.com9820017423

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 3, 2026